Search Results

Dapagliflozin 100 mg  | 99.74%

TargetMol

Dapagliflozin is a selective sodium-glucose co-transporter subtype 2 (SGLT2) inhibitor with antihyperglycemic activity.

More Information Supplier Page

RGB-286638 free base 5 mg  | Purity Not Available

TargetMol

RGB-286638 free base is a novel CDK inhibitor with IC50s of 1 nM/2 nM/3 nM/4 nM/5 nM for cyclin T1-CDK9/cyclin B1-CDK1/cyclin E-CDK2/cyclin D1-CDK4/cyclin E-CDK3/p35-CDK5 respectively; less potent against cyclin H-CDK7 and cyclin D3-CDK6.

More Information Supplier Page

Cinacalcet hydrochloride 10 mg  | 99.90%

TargetMol

Cinacalcet hydrochloride is a naphthalene derivative and CALCIMIMETIC AGENT that increases the sensitivity of PARATHYROID GLAND calcium-sensing receptors to serum calcium. This action reduces parathyroid hormone secretion and decreases serum calcium in the treatment of PARATHYROID DISEASES.

More Information Supplier Page

Cinacalcet hydrochloride 100 mg  | 99.90%

TargetMol

Cinacalcet hydrochloride is a naphthalene derivative and CALCIMIMETIC AGENT that increases the sensitivity of PARATHYROID GLAND calcium-sensing receptors to serum calcium. This action reduces parathyroid hormone secretion and decreases serum calcium in the treatment of PARATHYROID DISEASES.

More Information Supplier Page

Revaprazan hydrochloride 50 mg  | Purity Not Available

TargetMol

Revaprazan Hydrochloride is the hydrochloride salt form of a lipophilic, weak base with potassium-competitive acid blocking (P-CAB) activity.

More Information Supplier Page

Revaprazan hydrochloride 25 mg  | Purity Not Available

TargetMol

Revaprazan Hydrochloride is the hydrochloride salt form of a lipophilic, weak base with potassium-competitive acid blocking (P-CAB) activity.

More Information Supplier Page

Revaprazan hydrochloride 10 mg  | Purity Not Available

TargetMol

Revaprazan Hydrochloride is the hydrochloride salt form of a lipophilic, weak base with potassium-competitive acid blocking (P-CAB) activity.

More Information Supplier Page